NCT07694609Active, not recruiting
Integrated Clinical-Occupational Management for Workers With Chronic Noncommunicable Diseases
Evaluation of an Integrated Clinical-Occupational Management Pathway for the Global Health Protection of Workers With Chronic Noncommunicable Diseases
Source: ClinicalTrials.gov · Last updated 10 Jul 2026
Brief summary (registry, in English)
MCNT@WORK is a prospective multicenter observational study assessing how chronic noncommunicable diseases affect work ability, quality of life, psychological well-being, and occupational participation. It will enroll at least 200 working-age adults with inflammatory bowel disease or breast cancer, assessed at baseline and after 12 months. The study will collect clinical, functional, psychological, social, and occupational data to identify factors linked to reduced work ability, absenteeism, presenteeism, return-to-work barriers, or early labor-market exit. Findings will support an integrated clinical-occupational care pathway, combining specialist care and occupational medicine. The goal is to promote personalized support, safe return to work, job retention, and sustainable employment.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 3 Jul 2026
- Start date
- 23 Apr 2026
- Primary completion date
- 23 Oct 2027
- Lead sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Diseases
- Crohn's disease, Ulcerative colitis
- NCT number
- NCT07694609
What you commit to
- Study type: Observational
- Planned participants: 200
- From 23 Apr 2026 to the primary completion date, 23 Oct 2027
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Absence of a confirmed diagnosis of inflammatory bowel disease, including Crohn's disease or ulcerative colitis, or breast cancer.
- Acute clinical conditions or severe comorbidities that, in the opinion of the responsible physician, prevent participation in the study or correct completion of the assessment tools.
- Cognitive, linguistic, or psychiatric impairment affecting the ability to understand the information provided or to complete the questionnaires required by the protocol.
- Failure to provide written informed consent or refusal of personal data processing according to Regulation (EU) 2016/679 - GDPR.
Age
- Age \<18 years or \>70 years.
Who the study is looking for
- Age ≥18 years and \<70 years.
- Confirmed diagnosis of inflammatory bowel disease, including Crohn's disease or ulcerative colitis, or confirmed diagnosis of breast cancer.
- Patient under care at one of the participating clinical units.
- For patients with breast cancer: inclusion from diagnosis, during preparation for surgery or neoadjuvant chemotherapy, or during post-treatment follow-up.
- For patients with inflammatory bowel disease: confirmed diagnosis at any clinical stage and regardless of ongoing treatment.
- Ability to understand the aims of the study and to complete the questionnaires required by the protocol.
- Written informed consent to participate in the study and to the processing of personal data according to Regulation (EU) 2016/679 - GDPR.
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Università degli studi di Napoli Federico II Coordinator of this site? Confirm its status | Naples | Italy | Unknown status |
| Fondazione Policlinico Universitario A. Gemelli IRCCS Coordinator of this site? Confirm its status | Rome | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.